Clinical trials: To Compare Voriconazole and Amphotericin Sequential Itraconazole Therapy
Talaromyces in Human Immunodeficiency Virus Negative, To Compare Voriconazole and Amphotericin Sequential Itraconazole Therapy
Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy
Through a multi-center large-sample non-randomized controlled study, the effect of voriconazole, amphotericin B sequential itraconazole therapy on Talaromyces in Human Immunodeficiency Virus（HIV）negative hosts were compared to…
- Conditions
- Talaromyces in Human Immunodeficiency Virus Negative, To Compare Voriconazole and Amphotericin Sequential Itraconazole Therapy, To Dynamically Monitor the Anti-Interferon-γ Autoantibodies
- Trial name
- CSHHTVASIT (NCT03827278)
- Testing
- Voriconazole
- Where
- China
- Volunteers
- 200 people
- Sponsor
- Guangxi Medical University